Bulimia Nervosa

Bulimia nervosa is characterised by recurrent binge eating with compensatory behaviours (vomiting, laxatives, excessive exercise). Patients are often of normal weight.

Key Facts

Prevalence ~1-2%; F:M ~10:1; peak onset 18-25 years Recurrent binge eating (≥1/week for ≥3 months) with compensatory behaviours — diagnostic criteria Patients typically normal weight or slightly overweight — distinguishes from binge-purge AN First-line: CBT-BN (16-20 sessions) — NICE NG69; guided self-help as first step Fluoxetine 60mg OD reduces binge-purge frequency — recommended alongside or after CBT Hypokalaemic metabolic alkalosis from vomiting is the characteristic electrolyte disturbance Dental erosion (perimolysis), parotid enlargement, and Russell's sign are physical examination findings Comorbidity: Depression (~50%), anxiety, substance misuse, personality disorders

Overview

Key Facts

Bulimia nervosa involves cycles of binge eating and compensatory purging behaviours. Unlike anorexia, weight is often normal, which may delay recognition.

Epidemiology

Prevalence ~1-2%; F:M ~10:1. Peak onset 18-25 years. Higher prevalence in Western countries. Often hidden due to shame — average delay to treatment ~5 years.

Aetiology

  • Genetic: Heritability ~55-60%; shared genetic risk with AN and other psychiatric disorders
  • Cognitive: Overvaluation of shape/weight, dichotomous thinking, dietary restraint → binge → purge cycle
  • Neurobiological: Serotonergic dysfunction, altered reward pathways, impaired satiety signals
  • Environmental: Dieting, media pressure, peer influences, childhood adversity

Pathophysiology

  • Restrict-binge-purge cycle: Dietary restraint → physiological and psychological deprivation → binge eating → guilt/disgust → compensatory purging → temporary relief → continued restriction
  • Vomiting: Hypokalaemic metabolic alkalosis; dental erosion; Mallory-Weiss tears; parotid hypertrophy
  • Laxative abuse: Metabolic acidosis, dehydration, chronic constipation (lazy bowel)
  • Ipecac abuse: Cardiomyopathy (rare but potentially fatal)

Clinical Presentation

Core Features

  • Recurrent binge eating: Large amounts in short time, sense of loss of control
  • Compensatory behaviours: Self-induced vomiting, laxative/diuretic abuse, excessive exercise, fasting
  • Self-evaluation excessively influenced by body shape and weight
  • Normal or near-normal weight

Physical Signs

  • Russell's sign (calluses on knuckles)
  • Parotid gland enlargement ('chipmunk cheeks')
  • Dental erosion (perimolysis — especially lingual surfaces of upper teeth)
  • Periorbital petechiae (forceful vomiting)
  • Oedema (fluid shifts)

Red Flags

  • Severe hypokalaemia (<2.5 mmol/L) — cardiac arrhythmia risk
  • Haematemesis — Mallory-Weiss tear or Boerhaave syndrome
  • Syncope, palpitations — cardiac complications
  • Suicidal ideation — elevated risk

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
Anorexia nervosa (binge-purge type)BMI <17.5 with binge-purge behavioursBMI, clinical assessment
Binge eating disorderBinge eating without compensatory behavioursClinical history
DepressionOvereating/appetite change, but without purgingPHQ-9
Kleine-Levin syndromeEpisodic hypersomnia and hyperphagiaSleep study
GI disorderVomiting with organic causeOGD, bloods

Diagnosis / Investigation

Bedside

  • BMI: Usually normal (18.5-30)
  • Vital signs: HR, BP (postural drop if dehydrated)
  • ECG: QTc prolongation, U waves (hypokalaemia)
  • Dental examination: Erosion pattern

Bloods

  • U&Es: Hypokalaemia, hyponatraemia, raised urea (dehydration)
  • Bicarbonate: Elevated (metabolic alkalosis from vomiting) or low (laxative abuse)
  • Amylase: Raised (salivary, from vomiting)
  • FBC, LFTs, TFTs: Baseline
  • Phosphate, Mg²⁺: Electrolyte status

Special Tests

  • EDE-Q: Eating disorder severity assessment
  • SCOFF questionnaire: Screening

Management

Non-pharmacological (NICE NG69)

  • Step 1: Guided self-help based on CBT (4-9 sessions over 16 weeks)
  • Step 2: CBT-BN (16-20 sessions) — first-line definitive treatment; ~50% achieve abstinence from binge-purge behaviours
  • Alternative: Interpersonal therapy (IPT) if CBT not effective
  • Dietary guidance: Regular eating pattern (3 meals + 2-3 snacks), avoid dietary restriction

Pharmacological

  • Fluoxetine 60mg OD: Recommended alongside or after CBT; reduces binge-purge frequency by ~50%
  • Higher dose than for depression (60mg vs 20mg)
  • Other SSRIs have less evidence
  • Not recommended: TCAs (cardiac risk), MAOIs

Referral Criteria

  • Suspected bulimia — specialist eating disorder service
  • Medical complications — medical assessment
  • Failed guided self-help — step up to specialist CBT-BN
  • Severe electrolyte disturbance — urgent medical admission

Prognosis

  • CBT-BN: ~50% achieve remission; ~30% partial improvement; ~20% chronic course
  • Better prognosis than anorexia nervosa; lower mortality (SMR ~2×)
  • Recovery: ~50-70% recover with treatment; relapse common (30-50%)
  • Suicide: Elevated risk but lower than AN
  • Good prognostic factors: Shorter duration, earlier treatment, absence of comorbid personality disorder
  • Long-term dental damage may be permanent
  • Medical complications generally reversible with cessation of purging

Other Relevant Information

Electrolyte Patterns in Purging

Purging MethodElectrolyte Pattern
Self-induced vomitingHypokalaemic metabolic alkalosis
Laxative abuseHypokalaemic metabolic acidosis
Diuretic abuseHypokalaemic metabolic alkalosis
MixedVariable